CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Leverage Ratio

OXGN's quarterly Leverage Ratio and Total Liabilities, Equity growth




OXGN Leverage Ratio (Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
Y / Y Equity Change 230.49 % 181.28 % 25955.92 % 3041.58 % -
Y / Y Total Liabilities Change 262.16 % 302.11 % 759.59 % 373.35 % 87.61 %
Leverage Ratio MRQ 0.61 0.52 0.56 0.4 0.56
Overall Ranking # # # # #
Seq. Equity Change 0.42 % 4.54 % -10.59 % 252.09 % -14.53 %
Seq. Total Liabilities Change 18.58 % -3.16 % 25.08 % 152.12 % 31.67 %



Leverage Ratio third quarter 2020 Comment
Due to net new borrowings of 18.58%, Leverage Ratio detoriated to 0.61, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2020, 128 other companies have achieved lower Leverage Ratio than Mateon Therapeutics Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are OXGN Customers?
Leverage Ratio third quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 129
Healthcare Sector # 423
Overall Market # 1051


Leverage Ratio Statistics
High Average Low
17.02 0.83 0.02
(Sep 30 2018)   (Mar 31 2015)




Financial Statements
Mateon Therapeutics Inc's Equity $ 16 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Total Liabilities $ 10 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingSep 30 2020, within Biotechnology & Drugs Industry Leverage RatioSep 30 2020 MRQ Total LiabilitiesSep 30 2020 MRQ Equity
Adma Biologics Inc   1.66 $ 118.600  Millions$ 71.376  Millions
Scholar Rock Holding Corp  1.59 $ 100.444  Millions$ 62.977  Millions
Sunwin Stevia International Inc   1.56 $ 17.736  Millions$ 11.338  Millions
Merus N v   1.53 $ 128.992  Millions$ 84.501  Millions
Biogen Inc   1.32 $ 14,175.600  Millions$ 10,744.500  Millions
Acorda Therapeutics inc   1.27 $ 396.916  Millions$ 313.531  Millions
Royalty Pharma Plc  1.17 $ 11,428.865  Millions$ 9,798.648  Millions
Cidara Therapeutics Inc   1.15 $ 34.116  Millions$ 29.553  Millions
Wave Life Sciences Ltd   1.10 $ 118.958  Millions$ 108.241  Millions
Emergent Biosolutions Inc   1.09 $ 1,364.800  Millions$ 1,251.500  Millions
Predictive Oncology Inc   1.06 $ 12.924  Millions$ 12.237  Millions
Cel sci Corporation  1.05 $ 20.810  Millions$ 19.727  Millions
Obalon Therapeutics Inc  1.02 $ 6.040  Millions$ 5.922  Millions
Establishment Labs Holdings Inc   0.93 $ 74.727  Millions$ 79.957  Millions
Chromadex Corporation  0.92 $ 17.928  Millions$ 19.487  Millions
Neurocrine Biosciences Inc   0.87 $ 698.300  Millions$ 804.300  Millions
Armata Pharmaceuticals Inc   0.86 $ 21.056  Millions$ 24.619  Millions
Sangamo Therapeutics Inc   0.85 $ 442.299  Millions$ 520.881  Millions
Evelo Biosciences Inc   0.84 $ 42.297  Millions$ 50.430  Millions
Cyanotech Corp  0.83 $ 13.593  Millions$ 16.311  Millions
Pulmatrix Inc   0.83 $ 19.456  Millions$ 23.500  Millions
Solid Biosciences Inc   0.82 $ 18.287  Millions$ 22.231  Millions
Unity Biotechnology Inc   0.78 $ 76.870  Millions$ 98.101  Millions
Soligenix Inc   0.77 $ 5.730  Millions$ 7.405  Millions
Health Discovery Corp  0.77 $ 0.562  Millions$ 0.734  Millions
Aclaris Therapeutics Inc   0.75 $ 30.596  Millions$ 40.757  Millions
Allena Pharmaceuticals Inc   0.75 $ 13.623  Millions$ 18.179  Millions
Cv Sciences Inc   0.74 $ 14.370  Millions$ 19.449  Millions
Gritstone Oncology Inc   0.70 $ 50.524  Millions$ 71.984  Millions
Oncocyte Corp  0.67 $ 23.137  Millions$ 34.639  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BSM's Profile

Stock Price

BSM's Financials

Business Description

Fundamentals

Charts & Quotes

BSM's News

Suppliers

BSM's Competitors

Customers & Markets

Economic Indicators

BSM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071